Patents by Inventor Nada Porter

Nada Porter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9464322
    Abstract: The subject technology relates, in part, to a method of treating Alzheimer's Disease (AD), early-stage AD, elevated risk of AD, mild cognitive impairment (MCI), or other forms of age-related cognitive decline in a subject in need thereof by administering to the subject a molecule that promotes calcium-release stabilization in ryanodine receptors (RyRs) and/or inosital triphosphate receptors (InsP3Rs) in brain cells. Diagnostic methods using calcium-release stabilizing immunophilins, junctophilins or calmodulin are also disclosed.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: October 11, 2016
    Assignee: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: Philip W. Landfield, John Christopher Gant, Eric M. Blalock, Kuey-Chu Chen, Olivier Thibault, Nada Porter
  • Publication number: 20160281163
    Abstract: The subject technology relates, in part, to a method of treating Alzheimer's Disease (AD), early-stage AD, elevated risk of AD, mild cognitive impairment (MCI), or other forms of age-related cognitive decline in a subject in need thereof by administering to the subject a molecule that promotes calcium-release stabilization in ryanodine receptors (RyRs) and/or inosital triphosphate receptors (InsP3Rs) in brain cells. Diagnostic methods using calcium-release stabilizing immunophilins, junctophilins or calmodulin are also disclosed.
    Type: Application
    Filed: January 20, 2016
    Publication date: September 29, 2016
    Inventors: Philip W. Landfield, John Christopher Gant, Eric M. Blalock, Kuey-Chu Chen, Olivier Thibault, Nada Porter
  • Publication number: 20070082350
    Abstract: I Methods and kits for diagnosing Alzheimer's disease and/or incipient Alzheimer's disease are disclosed. The methods and kits of the invention utilize a set of genes and their encoded proteins that are shown to be correlated with incipient Alzheimer's disease.
    Type: Application
    Filed: August 9, 2006
    Publication date: April 12, 2007
    Inventors: Philip Landfield, Nada Porter, Kuey-Chu Chen, James Geddes, Eric Blalock